Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 22 for “"PBPK modelling"”.
-
Physiologically based Pharmacokinetic (PBPK) Modelling of Cisplatin in Rats and Humans
The physiologically based pharmacokinetic (PBPK) modelling has been accepted as one of the most effective mechanistic techniques to analyze pharmacokinetics (PK) of drugs in the drug development process. Its effectiveness in predicting the PK of drugs is important not only to the current drug …
-
Theory and application of PBPK modelling in drug development: the double-edged sword of complexity
Physiologically-based pharmacokinetic modelling has become an integral part of model-informed drug development. However, the extensive structure and parameterisation of such models may give rise to issues with model identifiability, parameter estimation and model analysis techniques. In this …
-
An investigation into paediatric gastrointestinal physiology and its applications in in silico pbpk modelling for age-appropriate formulations
… such as physiologically-based pharmacokinetic (PBPK) modelling and improve representability of paediatric subjects. This thesis specifically characterises (i) the abundance and ontogeny of paediatric intestinal drug metabolising enzymes and transporters (DMET) proteins and (ii) the amount of …
-
Combined fugacity-based exposure and PBPK modelling for human health risk assessment and risk management of trihalomethanes in indoor swimming pools
… Physiologically based pharmacokinetic (PBPK) models offer a more detailed way to assess human health risk. By modelling the absorption, distribution, metabolism and excretion of THMs, we can better predict the doses delivered to the most sensitive organs where the toxic effects occur. …
-
The application of mechanistic modelling as a tool in drug disposition and risk assessment
… of drug development. Pharmacokinetic modelling approaches, such as physiologically-based pharmacokinetic (PBPK) modelling, can cater to most of the critical PK issues and at the same time optimise the utilising of resources. The overall aim of this work was to illustrate, explore and …
-
Application of Model-Informed Precision Dosing to Complex Clinical Scenarios in Oncology: Case Studies of Rivaroxaban and Abiraterone
… of physiologically based pharmacokinetic (PBPK) modelling in the prospective interrogation of clinically relevant, albeit untested drug-drug-disease interactions. Rational dose adjustments were proposed, attesting to the capacity of PBPK modelling in facilitating optimization of a …
-
Physiologically Based Pharmacokinetic Modelling as a Tool for Dose Optimisation in Special Population Groups
… of physiologically based pharmacokinetic (PBPK) modelling, an approach that predicts drug disposition by integrating physiological and drug parameters. The objective is to elucidate the impact of physiological alterations within special populations on drug pharmacokinetics, aiming to …
-
Physiologically based pharmacokinetic modelling of antimalarial agents
… of physiologically based pharmacokinetic (PBPK) modelling in antimalarial drug research is evolving. Antimalarial agents are subject to drug-drug interactions (DDIs) and the resultant pharmacokinetics in special population groups is not well understood. To optimise antimalarial dosing in …
-
Small-scale in vitro methods for evaluating the impact of gastrointestinal transfer on luminal drug / drug product performance in the fasted state
… into physiologically based pharmacokinetic (PBPK) software and pharmacokinetic parameters estimated from simulated adult plasma profiles were compared with published values of pharmacokinetic parameters estimated from actual plasma data in healthy adults. Data from the biphasic dissolution …
-
The importance of measured rat tissue partition coefficients in physiological based pharmacokinetic modelling : and the impact on human translational strategies in early drug discovery
Physiologically based pharmacokinetic (PBPK) modelling is an established in silico platform for simulating pharmacokinetics in pre-clinical species and humans, and is widely used within drug metabolism and pharmacokinetics (DMPK) research to facilitate the design of drug molecules with human …
-
Mother matters - Advancing HIV therapy in pregnancy and lactation
… and women living with HIV, supplemented by PBPK modelling to predict concentrations in breastmilk. The observed and predicted concentrations were generally low and suggest no clinically relevant toxicity to infants. In addition, factors influencing the implementation of guideline changes …
-
Advancing chemical risk assessment through in silico new approach methodologies (NAMs): a quantitative adverse outcome network (qAON) framework linking perfluorooctanoic acid (PFOA) exposure to cardiovascular disease (CVD)-relevant mechanisms
… atmospheric dispersion and multimedia fate modelling, probabilistic exposure reconstruction, physiologically based pharmacokinetic (PBPK) modelling, human biomonitoring, liver transcriptomics, survey-weighted NHANES analysis, adverse outcome pathway (AOP) development, quantitative in …
-
Development towards prospective modelling of in vivo rabbit QTc prolongation
… ex vivo, in vivo) conducted and integrated using modelling/scaling approaches to develop compartmental and physiologically based models from early cardiovascular screening and pharmacokinetic data to predict measured in vivo rabbit QTc PKPD data. A terminally anaesthetised rabbit model was set-up …
-
Novel in vitro method to study the structured solubility of bioequivalent fasted intestinal media with other biopharmaceutical applications
… and physiology based pharmacokinetic (PBPK) modelling.
-
Use of Physiologically-Based Pharmacokinetic Modelling To Support Dose Optimization in The Critically Ill
… physiologically-based pharmacokinetic (PBPK) modelling are encouraging to overcome some of the current challenges and knowledge gaps towards optimizing drug therapy in critically ill patients. PBPK models leverage mechanistic principles to incorporate knowledge of physiology and drug …
-
Evaluation of prophylactic cefuroxime dose in obese pregnant women undergoing caesarean section
… and (4) A physiologically based pharmacokinetic (PBPK) obese–pregnant model was utilised to predict cefazolin and cefuroxime disposition in such population. At around 1–1.5 hours post cefuroxime 1500 mg dose, reported clinical cefuroxime plasma concentrations ranged within 8.7–57 mg/L in …
-
Development of Novel Excipient Screening Platform for Paediatric Oral Formulations
… for the first time, an attempt to integrate PBPK modelling to a paediatric specific formulation development approach to clinically inform an appropriate dosage form design and strategy was made. A 5 mg sustained release mini-tablet was successfully developed, with duration of release …
-
Current Challenges for the Development of Inhaled Medicines
… overestimation of particle sizes to improve modelling predictions due to constraints on diffusion, identifying a need to integrate in vitro dissolution methods with mechanistic models that account for pulmonary kinetics. Nor did the modelling account for reversible esterification, identifying …
-
In vitro and in silico profiling to assist pharmaceutical development
… of physiologically based pharmacokinetic modelling provides a potential solution by making use of the physico-chemical information along with the human physiology to simulate the clinical performance.;In this work an experimental approach is presented to study the in vitro solubility of …
-
Optimising Therapeutic Outcomes in CNS Disorders: Pharmaceutical and Pharmacokinetic Approaches
… of a phytochemical and the use of in-silico modelling to optimise antidepressant dosing in challenging populations such as pregnant women. The flavonoid hesperetin, as a potential candidate for CNS disorders, was incorporated into commercial base creams (Vanish-Pen™, Doublebase™ gel, …
Page 1 of 2